aspartic acid has been researched along with Hepatitis C in 9 studies
Aspartic Acid: One of the non-essential amino acids commonly occurring in the L-form. It is found in animals and plants, especially in sugar cane and sugar beets. It may be a neurotransmitter.
aspartic acid : An alpha-amino acid that consists of succinic acid bearing a single alpha-amino substituent
L-aspartic acid : The L-enantiomer of aspartic acid.
Hepatitis C: INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown.
| Excerpt | Relevance | Reference |
|---|---|---|
| "5 Tesla magnetic resonance scanner in HIV-infected subjects as follows: 12 subjects before (group 1) and after intensification of antiretroviral therapy with maraviroc (group 2) and 13 subjects with acute viral hepatitis C (HCV) co-infection (group 3)." | 3.81 | Differences in the variability of cerebral proton magnetic resonance spectroscopy (1H-MRS) measurements within three HIV-infected cohorts. ( Garvey, L; Rojas, JH; Taylor-Robinson, S; Vigneswaran, S; Winston, A, 2015) |
| "The enhanced liver fibrosis (ELF) index is a highly sensitive noninvasive marker of hepatic fibrosis that has had limited assessment in the HIV/HCV population." | 1.62 | The Enhanced Liver Fibrosis Index Predicts Hepatic Fibrosis Superior to FIB4 and APRI in HIV/HCV Infected Patients. ( Abdel-Hameed, EA; Kottilil, S; Rouster, SD; Sherman, KE, 2021) |
| "The prevalence of hepatotoxicity, liver fibrosis, and CKD were 7." | 1.51 | Evaluation of hepatic and kidney dysfunction among newly diagnosed HIV patients with viral hepatitis infection in Cape Coast, Ghana. ( Anabire, NG; Annan, I; Aryee, PA; Eliason, S; Hagan, OCK; Helegbe, GK; Luuse, AT; Obiri-Yaboah, D; Tetteh, WJ, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Pinto, L | 1 |
| Balbi, E | 1 |
| Halpern, M | 1 |
| Carius, L | 1 |
| Roma, J | 1 |
| Cardoso, SW | 1 |
| Grinsztejn, B | 1 |
| Veloso, VG | 1 |
| Pacheco, L | 1 |
| Perazzo, H | 1 |
| Abdel-Hameed, EA | 1 |
| Rouster, SD | 1 |
| Kottilil, S | 1 |
| Sherman, KE | 1 |
| Anabire, NG | 1 |
| Tetteh, WJ | 1 |
| Obiri-Yaboah, D | 1 |
| Annan, I | 1 |
| Luuse, AT | 1 |
| Aryee, PA | 1 |
| Helegbe, GK | 1 |
| Hagan, OCK | 1 |
| Eliason, S | 1 |
| Rollet-Kurhajec, KC | 1 |
| Moodie, EE | 1 |
| Walmsley, S | 1 |
| Cooper, C | 1 |
| Pick, N | 1 |
| Klein, MB | 1 |
| Vigneswaran, S | 1 |
| Rojas, JH | 1 |
| Garvey, L | 1 |
| Taylor-Robinson, S | 1 |
| Winston, A | 1 |
| Bokemeyer, M | 1 |
| Ding, XQ | 1 |
| Goldbecker, A | 1 |
| Raab, P | 1 |
| Heeren, M | 1 |
| Arvanitis, D | 1 |
| Tillmann, HL | 1 |
| Lanfermann, H | 1 |
| Weissenborn, K | 1 |
| Bladowska, J | 1 |
| Zimny, A | 1 |
| Kołtowska, A | 1 |
| Szewczyk, P | 1 |
| Knysz, B | 1 |
| Gąsiorowski, J | 1 |
| Furdal, M | 1 |
| Sąsiadek, MJ | 1 |
| Taylor, MJ | 1 |
| Letendre, SL | 1 |
| Schweinsburg, BC | 1 |
| Alhassoon, OM | 1 |
| Brown, GG | 1 |
| Gongvatana, A | 1 |
| Grant, I | 1 |
| Weiner, A | 1 |
| Erickson, AL | 1 |
| Kansopon, J | 1 |
| Crawford, K | 1 |
| Muchmore, E | 1 |
| Hughes, AL | 1 |
| Houghton, M | 1 |
| Walker, CM | 1 |
9 other studies available for aspartic acid and Hepatitis C
| Article | Year |
|---|---|
Effectiveness of Direct-acting Agents After Liver Transplantation A Real-life Study in Rio de Janeiro.
Topics: Antiviral Agents; Aspartic Acid; Biomarkers; Brazil; Carcinoma, Hepatocellular; Female; Hepacivirus; | 2022 |
The Enhanced Liver Fibrosis Index Predicts Hepatic Fibrosis Superior to FIB4 and APRI in HIV/HCV Infected Patients.
Topics: Aspartate Aminotransferases; Aspartic Acid; Biomarkers; Hepacivirus; Hepatitis C; Hepatitis C, Chron | 2021 |
Evaluation of hepatic and kidney dysfunction among newly diagnosed HIV patients with viral hepatitis infection in Cape Coast, Ghana.
Topics: Adult; Alanine Transaminase; Aspartic Acid; Blood Platelets; Coinfection; Cross-Sectional Studies; F | 2019 |
Hepatic Fibrosis Progression in HIV-Hepatitis C Virus Co-Infection--The Effect of Sex on Risk of Significant Fibrosis Measured by Aspartate-to-Platelet Ratio Index.
Topics: Adult; Antiretroviral Therapy, Highly Active; Aspartate Aminotransferases; Aspartic Acid; Biomarkers | 2015 |
Differences in the variability of cerebral proton magnetic resonance spectroscopy (1H-MRS) measurements within three HIV-infected cohorts.
Topics: Adult; Antiretroviral Therapy, Highly Active; Aspartic Acid; Basal Ganglia; Brain; Brain Chemistry; | 2015 |
Evidence for neuroinflammation and neuroprotection in HCV infection-associated encephalopathy.
Topics: Adult; Aged; Aspartic Acid; Brain; Brain Mapping; Case-Control Studies; Choline; Cognition Disorders | 2011 |
Evaluation of metabolic changes within the normal appearing gray and white matters in neurologically asymptomatic HIV-1-positive and HCV-positive patients: magnetic resonance spectroscopy and immunologic correlation.
Topics: Adult; Analysis of Variance; Anti-HIV Agents; Aspartic Acid; Brain; Case-Control Studies; Choline; C | 2013 |
Hepatitis C virus infection is associated with reduced white matter N-acetylaspartate in abstinent methamphetamine users.
Topics: Adult; Aspartic Acid; Brain; Female; Hepatitis C; Humans; Magnetic Resonance Imaging; Male; Methamph | 2004 |
Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant.
Topics: Amino Acid Sequence; Animals; Aspartic Acid; Base Sequence; CD8-Positive T-Lymphocytes; Cell Line; C | 1995 |